View in EDS HTML Full Text PDF Full Text

Monitoring and treatment disparities for youth on antipsychotics.

Saved in:
Bibliographic Details
Title: Monitoring and treatment disparities for youth on antipsychotics.
Authors: Fatica, Jack
Source: Brown University Child & Adolescent Behavior Letter. Aug2020, Vol. 36 Issue 8, p1-4. 4p.
Subject Terms: *Health services accessibility, *Adolescence, Antipsychotic agents, Drug monitoring, Health status indicators, Insurance, Medical prescriptions, Metabolic disorders, Race, Off-label use (Drugs), Inappropriate prescribing (Medicine), Disease risk factors
Abstract: The need for effective interventions in the management of neuropsychiatric conditions in youths has led to increased use of psychotropic medications, particularly antipsychotics. Several are approved by the Food and Drug Administration (FDA) for administration in youths to treat schizophrenia, bipolar disorder, autism‐related irritability, and Tourette's disorder. However, by and large, these medications are used off‐label to target dysregulated conduct or emotional features such as aggression (48% of treated symptoms), irritability (19%), and impulsivity (11%). Only 5% of prescriptions are for FDA‐approved indications. [ABSTRACT FROM AUTHOR]
Copyright of Brown University Child & Adolescent Behavior Letter is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Education Research Complete
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: ehh
DbLabel: Education Research Complete
An: 144334959
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Monitoring and treatment disparities for youth on antipsychotics.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Fatica%2C+Jack%22">Fatica, Jack</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Brown+University+Child+%26+Adolescent+Behavior+Letter%22">Brown University Child & Adolescent Behavior Letter</searchLink>. Aug2020, Vol. 36 Issue 8, p1-4. 4p.
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: *<searchLink fieldCode="DE" term="%22Health+services+accessibility%22">Health services accessibility</searchLink><br />*<searchLink fieldCode="DE" term="%22Adolescence%22">Adolescence</searchLink><br /><searchLink fieldCode="DE" term="%22Antipsychotic+agents%22">Antipsychotic agents</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+monitoring%22">Drug monitoring</searchLink><br /><searchLink fieldCode="DE" term="%22Health+status+indicators%22">Health status indicators</searchLink><br /><searchLink fieldCode="DE" term="%22Insurance%22">Insurance</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+prescriptions%22">Medical prescriptions</searchLink><br /><searchLink fieldCode="DE" term="%22Metabolic+disorders%22">Metabolic disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Race%22">Race</searchLink><br /><searchLink fieldCode="DE" term="%22Off-label+use+%28Drugs%29%22">Off-label use (Drugs)</searchLink><br /><searchLink fieldCode="DE" term="%22Inappropriate+prescribing+%28Medicine%29%22">Inappropriate prescribing (Medicine)</searchLink><br /><searchLink fieldCode="DE" term="%22Disease+risk+factors%22">Disease risk factors</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: The need for effective interventions in the management of neuropsychiatric conditions in youths has led to increased use of psychotropic medications, particularly antipsychotics. Several are approved by the Food and Drug Administration (FDA) for administration in youths to treat schizophrenia, bipolar disorder, autism‐related irritability, and Tourette's disorder. However, by and large, these medications are used off‐label to target dysregulated conduct or emotional features such as aggression (48% of treated symptoms), irritability (19%), and impulsivity (11%). Only 5% of prescriptions are for FDA‐approved indications. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Brown University Child & Adolescent Behavior Letter is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=ehh&AN=144334959
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cbl.30480
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 4
        StartPage: 1
    Subjects:
      – SubjectFull: Health services accessibility
        Type: general
      – SubjectFull: Adolescence
        Type: general
      – SubjectFull: Antipsychotic agents
        Type: general
      – SubjectFull: Drug monitoring
        Type: general
      – SubjectFull: Health status indicators
        Type: general
      – SubjectFull: Insurance
        Type: general
      – SubjectFull: Medical prescriptions
        Type: general
      – SubjectFull: Metabolic disorders
        Type: general
      – SubjectFull: Race
        Type: general
      – SubjectFull: Off-label use (Drugs)
        Type: general
      – SubjectFull: Inappropriate prescribing (Medicine)
        Type: general
      – SubjectFull: Disease risk factors
        Type: general
    Titles:
      – TitleFull: Monitoring and treatment disparities for youth on antipsychotics.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fatica, Jack
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: Aug2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 10581073
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Brown University Child & Adolescent Behavior Letter
              Type: main
ResultId 1